Table 3. Surgical procedures for interval debulking surgery and sites of first recurrence.
Variable | No. of case | Recurrence rate, n (%) | Recurrent sites* | ||||
---|---|---|---|---|---|---|---|
Dissemination | Lymph node | Distant organ | |||||
Peritoneal | Pleural | PAN, PLN | Distal LN | ||||
Surgical procedure | |||||||
TAH+BSO+OM (minimum) | 11 | 9 (82) | 6 | 0 | 3 | 1 | 0 |
TAH+BSO+OM | |||||||
+Excision of other organs (radical-1) | 16 | 15 (94) | 11 | 1 | 5 | 3 | 4 |
+Retroperitoneal lymphadenectomy (radical-2) | 48 | 36 (75) | 28 | 1 | 9 | 5 | 6 |
+Excision of other organs+retroperitoneal lymphadenectomy (radical-3) | 38 | 31 (82) | 25 | 2 | 8 | 4 | 3 |
LN status | |||||||
LN- group | 41 | 29 (71) | 24 | 1 | 7 | 4 | 4 |
LN+ group | 49 | 42 (86) | 32 | 2 | 11 | 6 | 5 |
U-LN group | 23 | 20 (87) | 14 | 1 | 7 | 3 | 4 |
Total | 113 | 91 (80.5) | 70 (61.9%) |
BSO, bilateral salpingo-oophorectomy; LN-, lymph node-negative; LN+, lymph node-positive; OM, omentectomy; PAN, para-aortic lymph node; PLN, pelvic lymph node; TAH, total abdominal hysterectomy; U-LN, unknown lymph node.
*In case of patients with multiple recurrent sites, we counted each site.